Evolus (EOLS) Financials

$12.08 +0.28 (+2.37%)

Closing price 05/2/2025 04:00 PM Eastern

Extended Trading

$11.75 -0.33 (-2.73%)

As of 05/2/2025 06:23 PM Eastern

Annual Income Statements for Evolus

This table shows Evolus' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-74	-62	-50
Consolidated Net Income / (Loss)	-74	-62	-50
Net Income / (Loss) Continuing Operations	-74	-62	-50
Total Pre-Tax Income	-74	-62	-50
Total Operating Income	-65	-49	-34
Total Gross Profit	90	138	182
Total Revenue	149	202	266
Operating Revenue	149	202	266
Total Cost of Revenue	59	65	84
Operating Cost of Revenue	59	65	84
Total Operating Expenses	155	187	217
Selling, General & Admin Expense	142	165	198
Research & Development Expense	6.74	15	9.17
Depreciation Expense	0.77	2.18	2.34
Other Operating Expenses / (Income)	-	4.26	7.18
Total Other Income / (Expense), net	-8.99	-12	-15
Interest Expense	9.10	14	19
Interest & Investment Income	0.12	0.86	3.26
Other Income / (Expense), net	-0.01	0.70	0.13
Income Tax Expense	0.10	0.18	0.66
Basic Earnings per Share	($1.33)	($1.08)	($0.81)
Weighted Average Basic Shares Outstanding	56.07M	56.92M	62.02M
Diluted Earnings per Share	($1.33)	($1.08)	($0.81)
Weighted Average Diluted Shares Outstanding	56.07M	56.92M	62.02M
Weighted Average Basic & Diluted Shares Outstanding	56.41M	57.94M	63.59M

This table shows Evolus' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-20	-13	-15	-18	-17	-12	-13	-11	-19	-6.79
Consolidated Net Income / (Loss)	-20	-13	-15	-18	-17	-12	-13	-11	-19	-6.79
Net Income / (Loss) Continuing Operations	-20	-13	-15	-18	-17	-12	-13	-11	-19	-6.79
Total Pre-Tax Income	-20	-13	-15	-18	-17	-12	-13	-11	-19	-6.35
Total Operating Income	-18	-11	-12	-15	-13	-8.64	-8.92	-7.70	-15	-2.31
Total Gross Profit	20	27	30	35	35	39	41	48	43	50
Total Revenue	34	44	42	49	50	61	59	67	61	79
Operating Revenue	34	44	42	49	50	61	59	67	61	79
Total Cost of Revenue	13	16	12	15	15	22	18	19	18	29
Operating Cost of Revenue	13	16	12	15	15	22	18	19	18	29
Total Operating Expenses	38	38	42	50	48	47	50	56	58	53
Selling, General & Admin Expense	35	37	37	41	43	43	45	50	53	50
Research & Development Expense	1.38	1.35	1.38	5.65	1.59	6.81	2.08	2.35	2.31	2.43
Depreciation Expense	0.92	-1.93	1.20	1.25	1.31	-1.58	1.41	1.43	1.09	-1.58
Total Other Income / (Expense), net	-2.37	-2.47	-2.73	-3.00	-3.46	-3.09	-4.14	-3.61	-3.56	-4.04
Interest Expense	2.34	2.63	2.79	3.18	3.79	4.08	4.70	4.70	4.76	4.57
Interest & Investment Income	0.04	0.08	0.10	0.16	0.31	0.29	0.52	1.03	0.93	0.79
Other Income / (Expense), net	-0.06	0.08	-0.04	0.02	0.02	0.69	0.05	0.06	0.27	-0.25
Income Tax Expense	0.01	0.06	0.02	0.02	0.02	0.11	0.05	0.04	0.13	0.44
Basic Earnings per Share	($0.36)	($0.24)	($0.26)	($0.32)	($0.30)	($0.20)	($0.22)	($0.18)	($0.30)	($0.11)
Weighted Average Basic Shares Outstanding	56.18M	56.07M	56.48M	56.92M	57.02M	56.92M	58.80M	62.72M	63.15M	62.02M
Diluted Earnings per Share	($0.36)	($0.24)	($0.26)	($0.32)	($0.30)	($0.20)	($0.22)	($0.18)	($0.30)	($0.11)
Weighted Average Diluted Shares Outstanding	56.18M	56.07M	56.48M	56.92M	57.02M	56.92M	58.80M	62.72M	63.15M	62.02M
Weighted Average Basic & Diluted Shares Outstanding	56.25M	56.41M	56.92M	56.97M	57.15M	57.94M	62.61M	63.09M	63.32M	63.59M

This table details how cash moves in and out of Evolus' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-92	8.92	24
Net Cash From Operating Activities	-85	-34	-18
Net Cash From Continuing Operating Activities	-85	-34	-18
Net Income / (Loss) Continuing Operations	-74	-62	-50
Consolidated Net Income / (Loss)	-74	-62	-50
Depreciation Expense	3.72	5.13	5.30
Amortization Expense	1.86	1.85	1.87
Non-Cash Adjustments To Reconcile Net Income	-2.57	17	25
Changes in Operating Assets and Liabilities, net	-14	3.37	0.55
Net Cash From Investing Activities	-2.94	-1.63	-4.82
Net Cash From Continuing Investing Activities	-2.94	-1.63	-4.82
Purchase of Property, Plant & Equipment	-2.94	-1.63	-4.82
Net Cash From Financing Activities	-4.15	45	47
Net Cash From Continuing Financing Activities	-4.15	45	47
Repayment of Debt	-0.50	-0.05	0.00
Repurchase of Common Equity	0.00	0.00	-0.25
Issuance of Debt	0.00	50	0.00
Issuance of Common Equity	0.00	0.00	51
Other Financing Activities, net	-3.65	-5.31	-3.55
Effect of Exchange Rate Changes	-0.34	-0.09	-0.48
Cash Interest Paid	8.00	13	18
Cash Income Taxes Paid	0.08	0.12	0.24

This table details how cash moves in and out of Evolus' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-19	-12	-22	10	-3.02	24	34	-3.29	-8.64	1.92
Net Cash From Operating Activities	-17	-8.77	-21	-13	-0.92	0.81	-11	-6.47	-5.72	4.81
Net Cash From Continuing Operating Activities	-17	-8.77	-21	-13	-0.92	0.81	-11	-6.47	-5.72	4.81
Net Income / (Loss) Continuing Operations	-20	-13	-15	-18	-17	-12	-13	-11	-19	-6.79
Consolidated Net Income / (Loss)	-20	-13	-15	-18	-17	-12	-13	-11	-19	-6.79
Depreciation Expense	0.92	1.03	1.20	1.25	1.31	1.37	1.41	1.43	1.09	1.37
Amortization Expense	0.47	0.48	0.51	0.49	0.43	0.42	0.43	0.44	0.47	0.54
Non-Cash Adjustments To Reconcile Net Income	3.11	2.65	-1.43	4.24	5.61	8.91	5.27	6.37	6.11	6.96
Changes in Operating Assets and Liabilities, net	-1.27	0.23	-6.07	-1.15	8.65	1.94	-4.61	-3.35	5.78	2.73
Net Cash From Investing Activities	-0.90	-1.39	-0.51	-0.22	-0.54	-0.36	-0.80	-1.25	-1.41	-1.36
Net Cash From Continuing Investing Activities	-0.90	-1.39	-0.51	-0.22	-0.54	-0.36	-0.80	-1.25	-1.41	-1.36
Purchase of Property, Plant & Equipment	-0.90	-1.39	-0.51	-0.22	-0.54	-0.36	-0.80	-1.25	-1.41	-1.36
Net Cash From Financing Activities	-0.76	-1.52	-1.28	24	-1.42	24	46	4.48	-1.42	-1.31
Net Cash From Continuing Financing Activities	-0.76	-1.52	-1.28	24	-1.42	24	46	4.48	-1.42	-1.31
Issuance of Common Equity	0.36	-0.54	0.03	0.11	0.06	-0.20	47	6.51	0.59	-3.38
Other Financing Activities, net	-1.11	-0.48	-1.31	-1.25	-1.48	-1.28	-1.83	-1.78	-2.01	2.06
Effect of Exchange Rate Changes	-0.20	0.03	-0.08	-0.05	-0.14	0.18	-0.13	-0.04	-0.09	-0.22
Cash Interest Paid	2.07	2.35	0.00	5.39	3.52	3.80	4.42	4.41	4.47	4.23
Cash Income Taxes Paid	0.02	0.01	0.03	0.03	0.04	0.02	0.03	0.14	0.03	0.04

This table presents Evolus' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	178	189	233
Total Current Assets	101	112	151
Cash & Equivalents	54	63	87
Accounts Receivable	22	31	48
Inventories, net	19	11	12
Prepaid Expenses	3.90	5.70	3.35
Other Current Assets	1.68	2.36	1.20
Plant, Property, & Equipment, net	2.62	2.09	3.22
Total Noncurrent Assets	75	74	78
Goodwill	21	21	21
Intangible Assets	49	47	49
Other Noncurrent Operating Assets	4.76	6.17	8.04
Total Liabilities & Shareholders' Equity	178	189	233
Total Liabilities	159	210	227
Total Current Liabilities	47	48	63
Accounts Payable	8.94	4.27	9.24
Accrued Expenses	25	34	41
Other Current Liabilities	13	10	13
Total Noncurrent Liabilities	113	161	164
Long-Term Debt	72	120	122
Noncurrent Deferred & Payable Income Tax Liabilities	0.02	0.03	0.01
Other Noncurrent Operating Liabilities	41	41	43
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	18	-21	5.52
Total Preferred & Common Equity	18	-21	5.52
Preferred Stock	0.00	0.00	0.00
Total Common Equity	18	-21	5.52
Common Stock	516	539	616
Retained Earnings	-497	-559	-609
Accumulated Other Comprehensive Income / (Loss)	-0.34	-0.43	-0.91

This table presents Evolus' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	193	160	169	168	226	234	230
Total Current Assets	116	84	96	92	150	158	150
Cash & Equivalents	66	31	42	39	97	94	85
Accounts Receivable	21	23	29	30	34	43	45
Inventories, net	22	23	20	18	12	13	15
Prepaid Expenses	3.66	4.16	4.30	3.66	5.68	5.51	3.40
Other Current Assets	4.23	1.59	1.60	1.57	1.84	2.43	2.39
Plant, Property, & Equipment, net	1.88	2.60	2.35	2.13	2.09	2.28	2.31
Total Noncurrent Assets	75	74	70	74	74	73	77
Goodwill	21	21	21	21	21	21	21
Intangible Assets	49	48	47	47	47	46	47
Other Noncurrent Operating Assets	4.58	4.42	1.75	6.13	6.02	5.87	9.14
Total Liabilities & Shareholders' Equity	193	160	169	168	226	234	230
Total Liabilities	163	153	176	187	208	214	224
Total Current Liabilities	51	41	41	49	47	54	61
Accounts Payable	8.56	10	7.84	12	11	10	14
Accrued Expenses	30	22	24	27	25	33	35
Other Current Liabilities	13	8.38	9.33	10	11	11	12
Total Noncurrent Liabilities	112	113	135	139	161	160	163
Long-Term Debt	72	72	95	95	121	121	121
Noncurrent Deferred & Payable Income Tax Liabilities	0.03	0.02	0.02	0.02	0.03	0.03	0.03
Other Noncurrent Operating Liabilities	40	41	40	44	40	39	42
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	29	6.95	-6.96	-19	18	19	5.89
Total Preferred & Common Equity	29	6.95	-6.96	-19	18	19	5.89
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	29	6.95	-6.96	-19	18	19	5.89
Common Stock	514	519	524	528	591	603	609
Retained Earnings	-484	-512	-530	-547	-572	-583	-603
Accumulated Other Comprehensive Income / (Loss)	-0.37	-0.42	-0.47	-0.61	-0.56	-0.60	-0.69

This table displays calculated financial ratios and metrics derived from Evolus' official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	49.10%	35.98%	31.76%
EBITDA Growth	-62.04%	30.46%	34.74%
EBIT Growth	-47.14%	25.72%	29.37%
NOPAT Growth	-47.12%	24.64%	30.11%
Net Income Growth	-58.97%	17.10%	18.26%
EPS Growth	-41.49%	18.80%	25.00%
Operating Cash Flow Growth	-154.32%	59.95%	47.07%
Free Cash Flow Firm Growth	10.82%	53.76%	21.55%
Invested Capital Growth	432.83%	1.03%	8.81%
Revenue Q/Q Growth	6.44%	9.39%	7.23%
EBITDA Q/Q Growth	11.22%	6.51%	16.85%
EBIT Q/Q Growth	10.27%	5.11%	13.55%
NOPAT Q/Q Growth	10.16%	3.91%	15.52%
Net Income Q/Q Growth	6.31%	2.12%	9.09%
EPS Q/Q Growth	13.07%	3.57%	10.00%
Operating Cash Flow Q/Q Growth	0.32%	21.99%	18.16%
Free Cash Flow Firm Q/Q Growth	1.78%	7.21%	18.50%
Invested Capital Q/Q Growth	3.10%	-0.56%	-4.72%
Profitability Metrics	-	-	-
Gross Margin	60.41%	68.08%	68.46%
EBITDA Margin	-40.21%	-20.56%	-10.18%
Operating Margin	-43.96%	-24.36%	-12.92%
EBIT Margin	-43.97%	-24.02%	-12.88%
Profit (Net Income) Margin	-50.07%	-30.52%	-18.94%
Tax Burden Percent	100.13%	100.29%	101.33%
Interest Burden Percent	113.74%	126.73%	145.13%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-211.24%	-94.05%	-62.64%
ROIC Less NNEP Spread (ROIC-NNEP)	-110.74%	-166.18%	-119.84%
Return on Net Nonoperating Assets (RNNOA)	62.97%	5,727.38%	727.50%
Return on Equity (ROE)	-148.27%	5,633.33%	664.86%
Cash Return on Invested Capital (CROIC)	-348.03%	-95.07%	-71.08%
Operating Return on Assets (OROA)	-30.01%	-26.45%	-16.27%
Return on Assets (ROA)	-34.18%	-33.62%	-23.92%
Return on Common Equity (ROCE)	-148.27%	5,633.33%	664.86%
Return on Equity Simple (ROE_SIMPLE)	-402.25%	298.15%	-913.08%
Net Operating Profit after Tax (NOPAT)	-46	-34	-24
NOPAT Margin	-30.77%	-17.05%	-9.05%
Net Nonoperating Expense Percent (NNEP)	-100.50%	72.13%	57.20%
Return On Investment Capital (ROIC_SIMPLE)	-50.60%	-34.58%	-18.96%
Cost of Revenue to Revenue	39.59%	31.92%	31.54%
SG&A Expenses to Revenue	95.44%	81.62%	74.37%
R&D to Revenue	4.54%	7.63%	3.44%
Operating Expenses to Revenue	104.37%	92.44%	81.39%
Earnings before Interest and Taxes (EBIT)	-65	-49	-34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-60	-42	-27
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	22.83	0.00	126.60
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.84	2.98	2.63
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	12.08	17.90	18.31
Enterprise Value to Revenue (EV/Rev)	2.96	3.26	2.76
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	3.89	-5.82	22.00
Long-Term Debt to Equity	3.89	-5.82	22.00
Financial Leverage	-0.57	-34.46	-6.07
Leverage Ratio	4.34	-167.57	-27.80
Compound Leverage Factor	4.93	-212.36	-40.34
Debt to Total Capital	79.53%	120.76%	95.65%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	79.53%	120.76%	95.65%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	20.47%	-20.76%	4.35%
Debt to EBITDA	-1.20	-2.90	-4.48
Net Debt to EBITDA	-0.30	-1.38	-1.27
Long-Term Debt to EBITDA	-1.20	-2.90	-4.48
Debt to NOPAT	-1.57	-3.49	-5.04
Net Debt to NOPAT	-0.39	-1.67	-1.43
Long-Term Debt to NOPAT	-1.57	-3.49	-5.04
Altman Z-Score	-2.33	-1.79	-0.71
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.17	2.33	2.40
Quick Ratio	1.64	1.93	2.14
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-75	-35	-27
Operating Cash Flow to CapEx	-2,889.15%	-2,090.23%	-373.19%
Free Cash Flow to Firm to Interest Expense	-8.28	-2.52	-1.46
Operating Cash Flow to Interest Expense	-9.33	-2.46	-0.96
Operating Cash Flow Less CapEx to Interest Expense	-9.66	-2.58	-1.22
Efficiency Ratios	-	-	-
Asset Turnover	0.68	1.10	1.26
Accounts Receivable Turnover	8.01	7.63	6.81
Inventory Turnover	5.71	4.32	7.25
Fixed Asset Turnover	74.55	85.94	100.31
Accounts Payable Turnover	7.83	9.77	12.43
Days Sales Outstanding (DSO)	45.56	47.84	53.60
Days Inventory Outstanding (DIO)	63.93	84.44	50.33
Days Payable Outstanding (DPO)	46.60	37.36	29.36
Cash Conversion Cycle (CCC)	62.90	94.93	74.58
Capital & Investment Metrics	-	-	-
Invested Capital	36	37	40
Invested Capital Turnover	6.86	5.51	6.92
Increase / (Decrease) in Invested Capital	30	0.38	3.24
Enterprise Value (EV)	440	659	734
Market Capitalization	422	602	699
Book Value per Share	$0.33	($0.36)	$0.09
Tangible Book Value per Share	($0.91)	($1.56)	($1.02)
Total Capital	90	100	127
Total Debt	72	120	122
Total Long-Term Debt	72	120	122
Net Debt	18	58	35
Capital Expenditures (CapEx)	2.94	1.63	4.82
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.37	1.29	1.43
Debt-free Net Working Capital (DFNWC)	54	64	88
Net Working Capital (NWC)	54	64	88
Net Nonoperating Expense (NNE)	29	27	26
Net Nonoperating Obligations (NNO)	18	58	35
Total Depreciation and Amortization (D&A)	5.58	6.98	7.17
Debt-free, Cash-free Net Working Capital to Revenue	0.25%	0.64%	0.54%
Debt-free Net Working Capital to Revenue	36.53%	31.73%	33.19%
Net Working Capital to Revenue	36.53%	31.73%	33.19%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($1.33)	($1.08)	($0.81)
Adjusted Weighted Average Basic Shares Outstanding	56.07M	56.92M	62.02M
Adjusted Diluted Earnings per Share	($1.33)	($1.08)	($0.81)
Adjusted Weighted Average Diluted Shares Outstanding	56.07M	56.92M	62.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	56.41M	57.94M	63.59M
Normalized Net Operating Profit after Tax (NOPAT)	-42	-34	-24
Normalized NOPAT Margin	-28.06%	-17.05%	-9.05%
Pre Tax Income Margin	-50.01%	-30.44%	-18.69%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-7.18	-3.51	-1.83
NOPAT to Interest Expense	-5.03	-2.49	-1.29
EBIT Less CapEx to Interest Expense	-7.51	-3.63	-2.09
NOPAT Less CapEx to Interest Expense	-5.35	-2.61	-1.54
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	-0.49%

This table displays calculated financial ratios and metrics derived from Evolus' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	27.07%	25.94%	23.04%	32.78%	47.55%	39.76%	42.21%	35.59%	22.12%	29.42%
EBITDA Growth	6.43%	45.51%	26.38%	33.40%	29.54%	31.98%	32.08%	56.75%	-16.81%	89.32%
EBIT Growth	6.02%	41.46%	21.85%	29.35%	25.28%	24.75%	26.50%	49.40%	-13.27%	67.67%
NOPAT Growth	6.35%	41.00%	22.06%	29.18%	24.90%	18.82%	25.90%	49.05%	-15.13%	73.20%
Net Income Growth	-4.34%	27.58%	15.48%	22.71%	16.54%	10.13%	11.37%	37.43%	-13.28%	42.60%
EPS Growth	-2.86%	45.45%	16.13%	23.81%	16.67%	16.67%	15.38%	43.75%	0.00%	45.00%
Operating Cash Flow Growth	46.92%	2.99%	46.11%	36.28%	94.58%	109.27%	48.44%	51.39%	-519.26%	491.39%
Free Cash Flow Firm Growth	-209.54%	43.87%	-7.63%	58.37%	71.07%	82.68%	96.52%	74.62%	-42.96%	24.25%
Invested Capital Growth	269.95%	432.83%	48.73%	36.08%	4.75%	1.03%	-11.38%	0.87%	13.56%	8.81%
Revenue Q/Q Growth	-8.78%	28.75%	-4.41%	18.28%	1.36%	21.95%	-2.73%	12.77%	-8.70%	29.24%
EBITDA Q/Q Growth	17.39%	45.43%	-14.66%	-28.83%	12.59%	47.32%	-14.50%	17.96%	-136.05%	95.18%
EBIT Q/Q Growth	15.97%	41.24%	-14.45%	-25.01%	11.13%	40.82%	-11.79%	13.93%	-98.95%	83.11%
NOPAT Q/Q Growth	16.17%	40.57%	-13.19%	-25.56%	11.10%	35.75%	-3.32%	13.67%	-100.90%	85.04%
Net Income Q/Q Growth	13.61%	35.08%	-12.36%	-22.64%	6.71%	30.09%	-10.80%	13.42%	-68.90%	64.57%
EPS Q/Q Growth	14.29%	33.33%	-8.33%	-23.08%	6.25%	33.33%	-10.00%	18.18%	-66.67%	63.33%
Operating Cash Flow Q/Q Growth	18.37%	48.54%	-134.64%	35.35%	93.06%	187.99%	-1,405.66%	39.05%	11.56%	184.03%
Free Cash Flow Firm Q/Q Growth	30.08%	3.31%	35.23%	4.92%	51.41%	42.10%	87.00%	-594.08%	-173.74%	69.32%
Invested Capital Q/Q Growth	4.24%	3.10%	30.38%	-2.88%	-19.76%	-0.56%	14.36%	10.54%	-9.66%	-4.72%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	60.21%	62.60%	70.89%	70.19%	69.15%	63.57%	69.55%	71.49%	70.17%	63.77%
EBITDA Margin	-48.88%	-20.72%	-24.85%	-27.07%	-23.34%	-10.08%	-11.87%	-8.64%	-22.33%	-0.83%
Operating Margin	-52.80%	-24.37%	-28.86%	-30.64%	-26.87%	-14.16%	-15.04%	-11.51%	-25.33%	-2.93%
EBIT Margin	-52.98%	-24.18%	-28.95%	-30.60%	-26.83%	-13.02%	-14.96%	-11.42%	-24.88%	-3.25%
Profit (Net Income) Margin	-59.81%	-30.16%	-35.45%	-36.76%	-33.83%	-19.40%	-22.09%	-16.96%	-31.38%	-8.60%
Tax Burden Percent	100.06%	100.43%	100.16%	100.13%	100.14%	100.90%	100.36%	100.38%	100.70%	106.93%
Interest Burden Percent	112.83%	124.20%	122.27%	119.99%	125.93%	147.65%	147.14%	148.00%	125.24%	247.41%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-229.76%	-117.11%	-79.51%	-90.31%	-95.98%	-54.65%	-51.59%	-41.24%	-111.32%	-14.21%
ROIC Less NNEP Spread (ROIC-NNEP)	-210.79%	-97.08%	-319.94%	-127.92%	-120.01%	-69.98%	-72.95%	-56.06%	-129.34%	-25.44%
Return on Net Nonoperating Assets (RNNOA)	136.02%	55.20%	-22.82%	-128.84%	-761.93%	2,411.86%	-184.62%	-364.83%	888.44%	154.44%
Return on Equity (ROE)	-93.74%	-61.91%	-102.33%	-219.15%	-857.92%	2,357.21%	-236.21%	-406.07%	777.12%	140.23%
Cash Return on Invested Capital (CROIC)	-341.54%	-348.03%	-148.24%	-127.93%	-103.72%	-95.07%	-59.94%	-59.29%	-84.79%	-71.08%
Operating Return on Assets (OROA)	-36.27%	-16.50%	-23.78%	-27.16%	-27.48%	-14.34%	-17.01%	-13.45%	-31.08%	-4.11%
Return on Assets (ROA)	-40.94%	-20.59%	-29.12%	-32.63%	-34.66%	-21.36%	-25.12%	-19.99%	-39.20%	-10.87%
Return on Common Equity (ROCE)	-93.74%	-61.91%	-102.33%	-219.15%	-857.92%	2,357.21%	-236.21%	-406.07%	777.12%	140.23%
Return on Equity Simple (ROE_SIMPLE)	-271.82%	0.00%	-1,031.83%	953.20%	325.37%	0.00%	-325.34%	-275.52%	-941.60%	0.00%
Net Operating Profit after Tax (NOPAT)	-13	-7.45	-8.43	-11	-9.41	-6.04	-6.25	-5.39	-11	-1.62
NOPAT Margin	-36.96%	-17.06%	-20.20%	-21.45%	-18.81%	-9.91%	-10.53%	-8.06%	-17.73%	-2.05%
Net Nonoperating Expense Percent (NNEP)	-18.97%	-20.04%	240.43%	37.61%	24.03%	15.33%	21.36%	14.83%	18.01%	11.23%
Return On Investment Capital (ROIC_SIMPLE)	-	-8.24%	-	-	-	-6.06%	-	-	-	-1.28%
Cost of Revenue to Revenue	39.79%	37.40%	29.11%	29.81%	30.85%	36.44%	30.45%	28.51%	29.83%	36.23%
SG&A Expenses to Revenue	102.64%	84.15%	89.60%	83.44%	86.62%	70.59%	76.05%	74.96%	85.96%	63.64%
R&D to Revenue	4.06%	3.09%	3.31%	11.45%	3.17%	11.16%	3.50%	3.51%	3.79%	3.08%
Operating Expenses to Revenue	113.00%	86.97%	99.75%	100.82%	96.02%	77.72%	84.59%	83.00%	95.50%	66.70%
Earnings before Interest and Taxes (EBIT)	-18	-11	-12	-15	-13	-7.94	-8.88	-7.64	-15	-2.57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-17	-9.04	-10	-13	-12	-6.15	-7.04	-5.78	-14	-0.66
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	15.45	22.83	68.68	0.00	0.00	0.00	43.98	35.17	173.54	126.60
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.23	2.84	3.05	2.45	2.82	2.98	3.69	2.86	4.12	2.63
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	12.94	12.08	10.89	10.12	15.58	17.90	19.82	15.18	25.16	18.31
Enterprise Value to Revenue (EV/Rev)	3.28	2.96	3.31	2.77	3.12	3.26	3.80	2.98	4.26	2.76
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.45	3.89	10.37	-13.62	-4.91	-5.82	6.54	6.26	20.58	22.00
Long-Term Debt to Equity	2.45	3.89	10.37	-13.62	-4.91	-5.82	6.54	6.26	20.58	22.00
Financial Leverage	-0.65	-0.57	0.07	1.01	6.35	-34.46	2.53	6.51	-6.87	-6.07
Leverage Ratio	3.22	4.34	5.13	9.52	36.61	-167.57	15.22	32.61	-29.50	-27.80
Compound Leverage Factor	3.64	5.39	6.28	11.43	46.11	-247.42	22.39	48.26	-36.94	-68.77
Debt to Total Capital	71.05%	79.53%	91.20%	107.92%	125.58%	120.76%	86.74%	86.23%	95.37%	95.65%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	71.05%	79.53%	91.20%	107.92%	125.58%	120.76%	86.74%	86.23%	95.37%	95.65%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	28.95%	20.47%	8.80%	-7.92%	-25.58%	-20.76%	13.26%	13.77%	4.63%	4.35%
Debt to EBITDA	-1.07	-1.20	-1.29	-1.92	-2.14	-2.90	-3.16	-3.95	-3.72	-4.48
Net Debt to EBITDA	-0.09	-0.30	-0.72	-1.08	-1.27	-1.38	-0.62	-0.89	-1.11	-1.27
Long-Term Debt to EBITDA	-1.07	-1.20	-1.29	-1.92	-2.14	-2.90	-3.16	-3.95	-3.72	-4.48
Debt to NOPAT	-1.41	-1.57	-1.66	-2.43	-2.65	-3.49	-3.74	-4.46	-4.25	-5.04
Net Debt to NOPAT	-0.12	-0.39	-0.94	-1.36	-1.57	-1.67	-0.73	-1.01	-1.27	-1.43
Long-Term Debt to NOPAT	-1.41	-1.57	-1.66	-2.43	-2.65	-3.49	-3.74	-4.46	-4.25	-5.04
Altman Z-Score	-1.04	-1.32	-1.55	-1.89	-1.75	-1.08	0.19	-0.15	0.40	-0.26
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.26	2.17	2.07	2.33	1.90	2.33	3.21	2.92	2.47	2.40
Quick Ratio	1.69	1.64	1.35	1.71	1.42	1.93	2.80	2.53	2.13	2.14
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-38	-37	-24	-23	-11	-6.42	-0.83	-5.79	-16	-4.86
Operating Cash Flow to CapEx	-1,896.66%	-630.77%	-4,028.77%	-6,162.04%	-171.43%	225.21%	-1,331.87%	-515.95%	-405.82%	353.01%
Free Cash Flow to Firm to Interest Expense	-16.36	-14.09	-8.61	-7.17	-2.93	-1.58	-0.18	-1.23	-3.33	-1.06
Operating Cash Flow to Interest Expense	-7.28	-3.33	-7.38	-4.18	-0.24	0.20	-2.26	-1.38	-1.20	1.05
Operating Cash Flow Less CapEx to Interest Expense	-7.66	-3.86	-7.56	-4.25	-0.39	0.11	-2.43	-1.64	-1.50	0.75
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.68	0.68	0.82	0.89	1.02	1.10	1.14	1.18	1.25	1.26
Accounts Receivable Turnover	8.16	8.01	7.77	6.74	7.19	7.63	7.62	6.58	6.61	6.81
Inventory Turnover	4.60	5.71	4.06	3.34	2.84	4.32	3.86	4.32	4.59	7.25
Fixed Asset Turnover	94.98	74.55	80.26	88.56	92.09	85.94	93.83	102.33	111.76	100.31
Accounts Payable Turnover	7.33	7.83	6.18	5.86	5.48	9.77	6.31	7.93	5.83	12.43
Days Sales Outstanding (DSO)	44.71	45.56	46.96	54.14	50.76	47.84	47.93	55.49	55.20	53.60
Days Inventory Outstanding (DIO)	79.38	63.93	89.99	109.22	128.50	84.44	94.56	84.44	79.51	50.33
Days Payable Outstanding (DPO)	49.82	46.60	59.09	62.24	66.64	37.36	57.88	46.02	62.59	29.36
Cash Conversion Cycle (CCC)	74.28	62.90	77.87	101.12	112.63	94.93	84.61	93.91	72.12	74.58
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	35	36	48	46	37	37	42	47	42	40
Invested Capital Turnover	6.22	6.86	3.94	4.21	5.10	5.51	4.90	5.12	6.28	6.92
Increase / (Decrease) in Invested Capital	26	30	16	12	1.68	0.38	-5.41	0.40	5.02	3.24
Enterprise Value (EV)	458	440	518	467	577	659	835	707	1,058	734
Market Capitalization	452	422	477	414	521	602	811	679	1,022	699
Book Value per Share	$0.52	$0.33	$0.12	($0.12)	($0.34)	($0.36)	$0.32	$0.31	$0.09	$0.09
Tangible Book Value per Share	($0.73)	($0.91)	($1.10)	($1.32)	($1.53)	($1.56)	($0.85)	($0.77)	($0.98)	($1.02)
Total Capital	101	90	79	88	76	100	139	140	127	127
Total Debt	72	72	72	95	95	120	121	121	121	122
Total Long-Term Debt	72	72	72	95	95	120	121	121	121	122
Net Debt	6.14	18	41	53	56	58	24	27	36	35
Capital Expenditures (CapEx)	0.90	1.39	0.51	0.22	0.54	0.36	0.80	1.25	1.41	1.36
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.90	0.37	12	13	4.77	1.29	6.51	10	4.51	1.43
Debt-free Net Working Capital (DFNWC)	65	54	43	55	43	64	103	104	90	88
Net Working Capital (NWC)	65	54	43	55	43	64	103	104	90	88
Net Nonoperating Expense (NNE)	7.75	5.72	6.36	7.56	7.52	5.79	6.86	5.96	8.34	5.17
Net Nonoperating Obligations (NNO)	6.14	18	41	53	56	58	24	27	36	35
Total Depreciation and Amortization (D&A)	1.39	1.51	1.71	1.74	1.74	1.79	1.83	1.86	1.56	1.91
Debt-free, Cash-free Net Working Capital to Revenue	-0.64%	0.25%	7.64%	7.95%	2.58%	0.64%	2.96%	4.36%	1.82%	0.54%
Debt-free Net Working Capital to Revenue	46.32%	36.53%	27.75%	32.69%	23.53%	31.73%	47.09%	43.84%	36.06%	33.19%
Net Working Capital to Revenue	46.32%	36.53%	27.75%	32.69%	23.53%	31.73%	47.09%	43.84%	36.06%	33.19%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.36)	($0.24)	($0.26)	($0.32)	($0.30)	($0.20)	($0.22)	($0.18)	($0.30)	($0.11)
Adjusted Weighted Average Basic Shares Outstanding	56.18M	56.07M	56.48M	56.92M	57.02M	56.92M	58.80M	62.72M	63.15M	62.02M
Adjusted Diluted Earnings per Share	($0.36)	($0.24)	($0.26)	($0.32)	($0.30)	($0.20)	($0.22)	($0.18)	($0.30)	($0.11)
Adjusted Weighted Average Diluted Shares Outstanding	56.18M	56.07M	56.48M	56.92M	57.02M	56.92M	58.80M	62.72M	63.15M	62.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	56.25M	56.41M	56.92M	56.97M	57.15M	57.94M	62.61M	63.09M	63.32M	63.59M
Normalized Net Operating Profit after Tax (NOPAT)	-12	-7.45	-7.27	-11	-8.15	-6.04	-5.14	-4.27	-11	-1.62
Normalized NOPAT Margin	-34.45%	-17.06%	-17.44%	-21.45%	-16.29%	-9.91%	-8.66%	-6.38%	-17.73%	-2.05%
Pre Tax Income Margin	-59.78%	-30.03%	-35.40%	-36.71%	-33.79%	-19.22%	-22.01%	-16.90%	-31.16%	-8.04%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-7.67	-4.01	-4.33	-4.75	-3.54	-1.95	-1.89	-1.63	-3.19	-0.56
NOPAT to Interest Expense	-5.35	-2.83	-3.02	-3.33	-2.48	-1.48	-1.33	-1.15	-2.27	-0.35
EBIT Less CapEx to Interest Expense	-8.05	-4.54	-4.51	-4.81	-3.69	-2.04	-2.06	-1.89	-3.49	-0.86
NOPAT Less CapEx to Interest Expense	-5.73	-3.36	-3.21	-3.39	-2.63	-1.57	-1.50	-1.42	-2.57	-0.65
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.49%

Frequently Asked Questions About Evolus' Financials

When does Evolus's fiscal year end?

According to the most recent income statement we have on file, Evolus' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Evolus' net income changed over the last 2 years?

Evolus' net income appears to be on a downward trend, with a most recent value of -$50.42 million in 2024, falling from -$74.41 million in 2022. The previous period was -$61.69 million in 2023. See Evolus' forecast for analyst expectations on what’s next for the company.

What is Evolus's operating income?

Evolus's total operating income in 2024 was -$34.41 million, based on the following breakdown:

Total Gross Profit: $182.30 million
Total Operating Expenses: $216.72 million

How has Evolus revenue changed over the last 2 years?

Over the last 2 years, Evolus' total revenue changed from $148.62 million in 2022 to $266.27 million in 2024, a change of 79.2%.

How much debt does Evolus have?

Evolus' total liabilities were at $227.05 million at the end of 2024, a 8.3% increase from 2023, and a 42.4% increase since 2022.

How much cash does Evolus have?

In the past 2 years, Evolus' cash and equivalents has ranged from $53.92 million in 2022 to $86.95 million in 2024, and is currently $86.95 million as of their latest financial filing in 2024.

How has Evolus' book value per share changed over the last 2 years?

Over the last 2 years, Evolus' book value per share changed from 0.33 in 2022 to 0.09 in 2024, a change of -73.5%.

Related Companies

This page (NASDAQ:EOLS) was last updated on 5/4/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Evolus (EOLS) Financials

Frequently Asked Questions About Evolus' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Evolus (EOLS) Financials

Annual Income Statements for Evolus

Quarterly Income Statements for Evolus

Annual Cash Flow Statements for Evolus

Quarterly Cash Flow Statements for Evolus

Annual Balance Sheets for Evolus

Quarterly Balance Sheets for Evolus

Annual Metrics and Ratios for Evolus

Quarterly Metrics and Ratios for Evolus

Frequently Asked Questions About Evolus' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools